Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TUB 040

Next Previous
Drug Profile

TUB 040

Alternative Names: TUB-040

Latest Information Update: 09 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tubulis
  • Class Alkaloids; Antibodies; Antineoplastics; Camptothecins; Drug conjugates; Immunoconjugates
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Non-small cell lung cancer; Ovarian cancer

Most Recent Events

  • 16 Feb 2026 Tubulis plans a phase I/II NAPISTAR 1-02 trial for Ovarian cancer (late-stage, Second-line therapy or greater, Recurrent, Combination therapy) in Belgium and Ukraine (IV, infusion) (CTIS2025-524691-33-00) in March 2026
  • 30 Oct 2025 Tubulis plans a pivotal trials for Solid tumour (Monotherapy, Combination therapy)
  • 19 Oct 2025 Efficacy and adverse events data from phase I/IIa clinical trials in Ovarian cancer released by Tubulis

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top